Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nueclear Healthcare is an India-based nuclear medicine and diagnostic imaging company focused on PET-CT and CT scan services, primarily for cancer detection, staging, and monitoring. The company operates a multi-center network of imaging facilities and also uses medical cyclotron infrastructure to produce radiotracers such as FDG, PSMA, and DOPA for scans. Nueclear is a wholly owned subsidiary of Thyrocare and is positioned as a low-cost, pan-India cancer diagnostics network. Its business is service-oriented rather than drug-development oriented, with revenue generated from imaging diagnostics rather than a therapeutic pipeline. The company is licensed by the Atomic Energy Regulatory Board and appears to be active and expanding its center footprint in India.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nuclear Healthcare.